Skip to content

HbA1c Diluting Solution

by Tosoh Corporation

Ref 0023503

HbA1c Diluting Solution (0023503) is an in vitro diagnostic device (EU IVDD general IVD; EU IVDD Class C; FDA Class II) made by Tosoh Corporation, registered in EUDAMED on 20 Jun 2022 (Basic UDI-DI B-04562185400571) and listed in FDA GUDID since 5 Jan 2026 (UDI-DI 04562185400571), active as of 7 Nov 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 7 Nov 2026.

Regulatory status

as of registry sync 7 Nov 2026

RegionAuthorizationNumberDateStatus
United StatesGUDID listing GUDID Number04562185400571 UDI-DI Date5 Jan 2026ListedStatusListed GUDID: in commercial distribution
European UnionCE/IVDD EUDAMED NumberB-04562185400571 Basic UDI-DI 04562185400571UDI-DIDate20 Jun 2022RegisteredStatusActive

Official records

From the FDA record

MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 23 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-04562185400571 registered 20 Jun 2022 Active
  • FDA GUDID UDI-DI 04562185400571 listed 5 Jan 2026 Listed

Timeline

2 dated events

  1. Registered EUDAMED B-04562185400571
  2. Listed FDA GUDID 04562185400571

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Generic name
Glycated haemoglobin (HbA1c) IVD, kit, liquid chromatography
Model / reference
0023503
Primary DI / UDI-DI
04562185400571
Basic UDI-DI
B-04562185400571, 45601892100030167M
FDA product code
LCP, PDJ
EMDN code
W01019001, W0101050302
GMDN term
Glycated haemoglobin (HbA1c) IVD, kit, liquid chromatography
Device class
Class IVD General EUDAMED
Class C EUDAMED
Class II GUDID
Regulation number
864.7470, 862.1373
EU registration type
Legacy device (under a directive)
Standard device
EU market of registration
Belgium
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
Class C
GUDID
Class II

Device class is stated on each registry's own scale: Class IVD General and Class C in the EU (EUDAMED), Class II in the US (FDA GUDID). EU and US classes are different schemes.

Manufacturer details

EUDAMED SRN
JP-MF-000024143
Authorised representative
Tosoh Europe N.V. BE-AR-000000211

Similar devices in this category

Other devices filed under CALIBRATORS SINGLE COMPONENT (CC).

Other devices from Tosoh Corporation

See all devices from Tosoh Corporation →

Properties

  • Single use
  • Reagent
  • Professional testing
  • Prescription use
  • Lot / batch number
  • Expiration date
Other properties (20, all answered No)